Saeed Bohlega Selected Research

Woodhouse Sakati syndrome

1/2022	Multimodal Evoked Potential Profiles in Woodhouse-Sakati Syndrome.
12/2008	Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saeed Bohlega Research Topics

Disease

4	Dyskinesias (Dyskinesia) 11/2016 - 04/2003
3	Dystonia (Limb Dystonia) 01/2021 - 06/2006
3	Movement Disorders (Movement Disorder) 04/2018 - 01/2015
3	Multiple Sclerosis 01/2017 - 11/2007
2	Woodhouse Sakati syndrome 01/2022 - 12/2008
2	COVID-19 11/2021 - 06/2021
2	Relapsing-Remitting Multiple Sclerosis 09/2021 - 06/2020
2	Stroke (Strokes) 01/2017 - 10/2009
2	Parkinson Disease (Parkinson's Disease) 01/2015 - 10/2006
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2012 - 12/2011
2	CADASIL 05/2008 - 11/2007
1	Intracranial Vasospasm 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Poisoning 01/2022
1	Infections 06/2021
1	Hereditary Spastic Paraplegia 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2016
1	Spontaneous Abortion (Miscarriage) 01/2016
1	Glycogen Storage Disease Type II (Pompe's Disease) 10/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2014
1	Headache (Headaches) 09/2014
1	Juvenile Amyotrophic Lateral Sclerosis 2 10/2012
1	Chronic Disease (Chronic Diseases) 04/2010
1	MELAS Syndrome (Syndrome, MELAS) 10/2009
1	Alopecia (Baldness) 01/2007
1	Deafness (Deaf Mutism) 01/2007
1	Diabetes Mellitus 01/2007
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2007
1	Hypokinesia (Bradykinesia) 10/2006
1	Lafora Disease 10/2003
1	Epilepsy (Aura) 10/2003
1	Atrophy 04/2003
1	Abnormal Reflex (Hyperreflexia) 04/2003
1	Seizures (Absence Seizure) 04/2003
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 05/2002

Drug/Important Bio-Agent (IBA)

4	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 04/2014
2	IronIBA 01/2022 - 05/2016
2	TabletsIBA 09/2021 - 06/2021
2	Cladribine FDA LinkGeneric 09/2021 - 06/2021
2	Type A Botulinum Toxins (Botox)FDA Link 11/2016 - 04/2014
2	Levodopa (L Dopa)FDA LinkGeneric 01/2015 - 10/2006
2	Mitochondrial DNA (mtDNA)IBA 10/2009 - 05/2008
1	PerfumeIBA 01/2022
1	Methanol (Carbinol)IBA 01/2022
1	VaccinesIBA 11/2021
1	teriflunomideIBA 06/2021
1	siponimodIBA 06/2021
1	Dimethyl FumarateIBA 06/2021
1	Natalizumab (Tysabri)FDA Link 06/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 06/2021
1	Interferon-betaIBA 06/2021
1	Alemtuzumab (Campath)FDA Link 06/2021
1	ocrelizumabIBA 06/2021
1	Pharmaceutical PreparationsIBA 06/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	InterferonsIBA 01/2016
1	alpha-Glucosidases (Acid Maltase)IBA 10/2015
1	GlycogenIBA 10/2015
1	EnzymesIBA 10/2015
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2015
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	LipidsIBA 10/2012
1	Sigma-1 ReceptorIBA 12/2011
1	DNA (Deoxyribonucleic Acid)IBA 10/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2008
1	Epidermal Growth Factor (EGF)IBA 11/2007
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2007
1	Testosterone (Sustanon)FDA Link 01/2007
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2007
1	PTEN-induced putative kinaseIBA 10/2006
1	polyglucosanIBA 10/2003
1	Lipoproteins (Lipoprotein)IBA 04/2003
1	Dual-Specificity PhosphatasesIBA 05/2002

Therapy/Procedure

12	Therapeutics 06/2021 - 10/2006
2	Injections 01/2021 - 11/2016
1	Pallidotomy 06/2006
1	Deep Brain Stimulation 06/2006